ヒトオルガノイドの市場規模、シェア、動向分析レポート：製品別、供給源別、臓器タイプ別、用途別、最終用途別、地域別、セグメント予測、2025～2030年

ヒトオルガノイド市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のヒトオルガノイド市場規模は2030年までに27億2,000万米ドルに達すると予測され、2025年から2030年までのCAGRは22.8％で成長すると予測されています。

同市場は、幹細胞研究や3D細胞培養技術の進歩に牽引され、大きな成長を遂げています。

市場の主要促進要因の1つは、個別化医療に対する需要の高まりです。患者固有の幹細胞から得られたオルガノイドは、個々の疾患メカニズムを研究し、オーダーメイドの治療アプローチをテストするためのユニークなプラットフォームを提供します。この能力は、腫瘍由来のオルガノイドを用いて化学療法や標的療法に対する患者の反応を予測できる腫瘍学において特に価値があります。ヘルスケアが個別化治療戦略にシフトするにつれて、オルガノイドベースのモデルの採用は増加し、市場の成長をさらに促進すると予想されます。

さらに、がん、神経変性疾患、肝疾患などの慢性疾患の有病率が高まっていることも、市場拡大を促す大きな要因となっています。オルガノイドは、これらの病態を研究するための高度なモデルを提供し、疾病メカニズムのより深い理解と新規治療介入の開発につながります。例えば、脳オルガノイドはアルツハイマー病やパーキンソン病のような神経疾患の研究に使用されており、肝臓オルガノイドや腎臓オルガノイドは臓器不全の治療法開発に役立っています。

こうした前向きな動向にもかかわらず、倫理的な懸念、規制上のハードル、オルガノイド開発に伴う高コストといった課題が、ある程度の制約をもたらす可能性があります。しかし、現在進行中の研究努力と技術の進歩がこれらの課題を解決し、生物医学および臨床応用におけるオルガノイドの広範な採用への道を開くと期待されています。

ヒトオルガノイド市場レポート・ハイライト

• 製品別では、オルガノイドモデルセグメントが2024年の市場を独占しました。この大きなシェアは、創薬、疾患モデリング、再生医療の採用が増加していることによる。
• 臓器タイプ別では、肝臓セグメントが2024年の市場を席巻。薬物代謝や毒性試験における重要な役割が大きなシェアを占めています。
• 供給源別では、成人幹細胞セグメントが2024年のヒトオルガノイド市場をリード。
• 用途別では、発生生物学が2024年のヒトオルガノイド市場を独占しました。この大きなシェアは、細胞プロセスの理解、組織工学、オルガノイド開発における重要な役割による。
• 最終用途別では、創薬、前臨床試験、個別化医療におけるオルガノイド技術の採用増加により、製薬・バイオテクノロジー企業が2024年に最大の市場シェアを占めました。
• 2024年には、北米がヒトオルガノイド市場をリードしました。バイオテクノロジーへの旺盛な投資、先進ヘルスケア・インフラ、創薬や個別化医療におけるオルガノイド技術の採用増加などがその要因です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヒトオルガノイド市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ヒトオルガノイド市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 ヒトオルガノイド市場：製品別推定・動向分析

• 製品セグメントダッシュボード
• 世界のヒトオルガノイド市場の製品別変動分析
• 世界のヒトオルガノイド市場規模と動向分析（製品別、2018～2030年）
• メディアとサプリメント
• 試薬
• オルガノイドモデル

第5章 ヒトオルガノイド市場：供給源別推定・動向分析

• ソースセグメントダッシュボード
• 世界のヒトオルガノイド市場の変動分析
• 世界のヒトオルガノイド市場規模と動向分析（供給源別、2018～2030年）
• 成体幹細胞
• 誘導多能性幹細胞
• 胚性幹細胞
• その他の情報源

第6章 ヒトオルガノイド市場：臓器タイプ別推定・動向分析

• 臓器タイプセグメントダッシュボード
• 世界のヒトオルガノイド市場：臓器タイプ別変動分析
• 世界のヒトオルガノイド市場規模と動向分析（臓器タイプ別、2018～2030年）
• 胃モデル
• 腸モデル
• 肝臓モデル
• 膵臓モデル
• 肺モデル
• 脳モデル
• 腎臓モデル
• その他のモデル

第7章 ヒトオルガノイド市場：用途別推定・動向分析

• アプリケーションセグメントダッシュボード
• 世界のヒトオルガノイド市場の用途別変動分析
• 世界のヒトオルガノイド市場規模と動向分析（用途別、2018～2030年）
• 発生生物学
• 薬物毒性および有効性試験
• 病気の病理学
• パーソナライズ医療
• 再生医療

第8章 ヒトオルガノイド市場：最終用途別推定・動向分析

• 最終用途セグメントダッシュボード
• 世界のヒトオルガノイド市場の最終用途別変動分析
• 世界のヒトオルガノイド市場規模と動向分析（最終用途別、2018～2030年）
• 製薬・バイオテクノロジー企業
• CROとCMO
• 学術調査機関
• その他の用途

第9章 ヒトオルガノイド市場：製品、臓器の種類、供給源、用途、最終用途別の地域別推定・動向分析

• 地域別市場シェア分析、2024年および2030年
• 地域別市場ダッシュボード
• 市場規模と予測動向分析、2018年から2030年まで：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/リスト
  • ATCC
  • Thermo Fisher Scientific Inc.
  • STEMCELL Technologies
  • Merck KGaA
  • Corning Incorporated
  • Bio-Techne.
  • ACROBiosystems.
  • .AMSBIO
  • Qkine Ltd.
  • PRIMACYT Cell Culture Technology GmbH

List of Tables

• Table 1 List of abbreviation
• Table 2 Global human organoids market, by region, 2018 - 2030 (USD Million)
• Table 3 Global human organoids market, by product, 2018 - 2030 (USD Million)
• Table 4 Global human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 5 Global human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 6 Global human organoids market, by application, 2018 - 2030 (USD Million)
• Table 7 Global human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 8 North America human organoids market, by country, 2018 - 2030 (USD Million)
• Table 9 North America human organoids market, by product, 2018 - 2030 (USD Million)
• Table 10 North America human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 11 North America human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 12 North America human organoids market, by application, 2018 - 2030 (USD Million)
• Table 13 North America human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 14 U.S. human organoids market, by product, 2018 - 2030 (USD Million)
• Table 15 U.S. human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 16 U.S. human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 17 U.S. human organoids market, by application, 2018 - 2030 (USD Million)
• Table 18 U.S. human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 19 Canada human organoids market, by product, 2018 - 2030 (USD Million)
• Table 20 Canada human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 21 Canada human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 22 Canada human organoids market, by application, 2018 - 2030 (USD Million)
• Table 23 Canada human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 24 Mexico human organoids market, by product, 2018 - 2030 (USD Million)
• Table 25 Mexico human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 26 Mexico human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 27 Mexico human organoids market, by application, 2018 - 2030 (USD Million)
• Table 28 Mexico human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 29 Europe human organoids market, by country, 2018 - 2030 (USD Million)
• Table 30 Europe human organoids market, by product, 2018 - 2030 (USD Million)
• Table 31 Europe human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 32 Europe human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 33 Europe human organoids market, by application, 2018 - 2030 (USD Million)
• Table 34 Europe human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 35 Germany human organoids market, by product, 2018 - 2030 (USD Million)
• Table 36 Germany human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 37 Germany human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 38 Germany human organoids market, by application, 2018 - 2030 (USD Million)
• Table 39 Germany human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 40 UK human organoids market, by product, 2018 - 2030 (USD Million)
• Table 41 UK human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 42 UK human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 43 UK human organoids market, by application, 2018 - 2030 (USD Million)
• Table 44 UK human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 45 France human organoids market, by product, 2018 - 2030 (USD Million)
• Table 46 France human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 47 France human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 48 France human organoids market, by application, 2018 - 2030 (USD Million)
• Table 49 France human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 50 Italy human organoids market, by product, 2018 - 2030 (USD Million)
• Table 51 Italy human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 52 Italy human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 53 Italy human organoids market, by application, 2018 - 2030 (USD Million)
• Table 54 Italy human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 55 Spain human organoids market, by product, 2018 - 2030 (USD Million)
• Table 56 Spain human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 57 Spain human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 58 Spain human organoids market, by application, 2018 - 2030 (USD Million)
• Table 59 Spain human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 60 Denmark human organoids market, by product, 2018 - 2030 (USD Million)
• Table 61 Denmark human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 62 Denmark human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 63 Denmark human organoids market, by application, 2018 - 2030 (USD Million)
• Table 64 Denmark human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 65 Sweden human organoids market, by product, 2018 - 2030 (USD Million)
• Table 66 Sweden human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 67 Sweden human organoids market, by sources, 2018 - 2030 (USD Million
• Table 68 Sweden human organoids market, by application, 2018 - 2030 (USD Million
• Table 69 Sweden human organoids market, by end use, 2018 - 2030 (USD Million
• Table 70 Norway human organoids market, by product, 2018 - 2030 (USD Million)
• Table 71 Norway human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 72 Norway human organoids market, by sources, 2018 - 2030 (USD Million
• Table 73 Norway human organoids market, by application, 2018 - 2030 (USD Million
• Table 74 Norway human organoids market, by end use, 2018 - 2030 (USD Million
• Table 75 Asia Pacific human organoids market, by country, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific human organoids market, by product, 2018 - 2030 (USD Million)
• Table 77 Asia Pacific human organoids market, by sources, 2018 - 2030 (USD Million
• Table 78 Asia Pacific human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 79 Asia Pacific human organoids market, by application, 2018 - 2030 (USD Million
• Table 80 Asia Pacific human organoids market, by end use, 2018 - 2030 (USD Million
• Table 81 China human organoids market, by product, 2018 - 2030 (USD Million)
• Table 82 China human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 83 China human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 84 China human organoids market, by application, 2018 - 2030 (USD Million)
• Table 85 China human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 86 Japan human organoids market, by product, 2018 - 2030 (USD Million)
• Table 87 Japan human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 88 Japan human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 89 Japan human organoids market, by application, 2018 - 2030 (USD Million)
• Table 90 Japan human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 91 India human organoids market, by product, 2018 - 2030 (USD Million)
• Table 92 India human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 93 India human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 94 India human organoids market, by application, 2018 - 2030 (USD Million)
• Table 95 India human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 96 South Korea human organoids market, by product, 2018 - 2030 (USD Million)
• Table 97 South Korea human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 98 South Korea human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 99 South Korea human organoids market, by application, 2018 - 2030 (USD Million)
• Table 100 South Korea human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 101 Australia human organoids market, by product, 2018 - 2030 (USD Million)
• Table 102 Australia human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 103 Australia human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 104 Australia human organoids market, by application, 2018 - 2030 (USD Million)
• Table 105 Australia human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 106 Thailand human organoids market, by product, 2018 - 2030 (USD Million)
• Table 107 Thailand human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 108 Thailand human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 109 Thailand human organoids market, by application, 2018 - 2030 (USD Million)
• Table 110 Thailand human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 111 Latin America human organoids market, by country, 2018 - 2030 (USD Million)
• Table 112 Latin America human organoids market, by product, 2018 - 2030 (USD Million)
• Table 113 Latin America human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 114 Latin America human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 115 Latin America human organoids market, by application, 2018 - 2030 (USD Million)
• Table 116 Latin America human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 117 Brazil human organoids market, by product, 2018 - 2030 (USD Million)
• Table 118 Brazil human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 119 Brazil human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 120 Brazil human organoids market, by application, 2018 - 2030 (USD Million)
• Table 121 Brazil human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 122 Argentina human organoids market, by product, 2018 - 2030 (USD Million)
• Table 123 Argentina human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 124 Argentina human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 125 Argentina human organoids market, by application, 2018 - 2030 (USD Million)
• Table 126 Argentina human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 127 MEA human organoids market, by country, 2018 - 2030 (USD Million)
• Table 128 MEA human organoids market, by product, 2018 - 2030 (USD Million)
• Table 129 MEA human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 130 MEA human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 131 MEA human organoids market, by application, 2018 - 2030 (USD Million)
• Table 132 MEA human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 133 South Africa human organoids market, by product, 2018 - 2030 (USD Million)
• Table 134 South Africa human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 135 South Africa human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 136 South Africa human organoids market, by application, 2018 - 2030 (USD Million)
• Table 137 South Africa human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 138 Saudi Arabia human organoids market, by product, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia human organoids market, by application, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 143 UAE human organoids market, by product, 2018 - 2030 (USD Million)
• Table 144 UAE human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 145 UAE human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 146 UAE human organoids market, by application, 2018 - 2030 (USD Million)
• Table 147 UAE human organoids market, by end use, 2018 - 2030 (USD Million)
• Table 148 Kuwait human organoids market, by product, 2018 - 2030 (USD Million)
• Table 149 Kuwait human organoids market, by organ type, 2018 - 2030 (USD Million)
• Table 150 Kuwait human organoids market, by sources, 2018 - 2030 (USD Million)
• Table 151 Kuwait human organoids market, by application, 2018 - 2030 (USD Million)
• Table 152 Kuwait human organoids market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 Human organoids market: Market outlook
• Fig. 5 Human organoids market: Segment outlook
• Fig. 6 Human organoids market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 Human organoids market driver impact
• Fig. 9 Human organoids market restraint impact
• Fig. 10 Human organoids market: Product outlook and key takeaways
• Fig. 11 Human organoids market: Product movement analysis
• Fig. 12 Media & supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 13 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Organoid Models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Human organoids market: Source outlook and key takeaways
• Fig. 16 Human organoids market: Source movement analysis
• Fig. 17 Adult stem cells market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Induced pluripotent stem cells market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Embryonic stem cells market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Other sources market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Human organoids market: Organ type outlook and key takeaways
• Fig. 22 Human organoids market: Organ type movement analysis
• Fig. 23 Stomach models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Intestine models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Liver models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Pancreatic models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Lung models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Brain models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Kidney models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Other models market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Human organoids market: Application outlook and key takeaways
• Fig. 32 Human organoids market: Application movement analysis
• Fig. 33 Developmental biology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030 (USD Million
• Fig. 35 Disease pathology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Personalized medicine market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Regenerative medicine market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Human organoids market: End use outlook and key takeaways
• Fig. 39 Human organoids market: End use movement analysis
• Fig. 40 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 CROs & CMOs market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 42 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 43 Other end use market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 44 Global human organoids market: Regional outlook and key takeaways
• Fig. 45 Global human organoids market: Regional movement analysis
• Fig. 46 North America human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 U.S. human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Canada human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Mexico human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Europe human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 UK human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Germany human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 France human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Italy human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Spain human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Denmark human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Sweden human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Norway human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Asia Pacific human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 China human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Japan human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 India human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Thailand human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 South Korea human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Australia human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Latin America human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Brazil human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Argentina human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Middle East and Africa human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 South Africa human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Saudi Arabia human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 UAE human organoids market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Kuwait human organoids market estimates and forecasts, 2018 - 2030 (USD Million)

Human Organoids Market Growth & Trends:

The global human organoids market size is anticipated to reach USD 2.72 billion by 2030 and is projected to grow at a CAGR of 22.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by advancements in stem cell research and 3D cell culture technologies.

One of the key drivers of the market is the rising demand for personalized medicine. Organoids derived from patient-specific stem cells offer a unique platform for studying individual disease mechanisms and testing tailored treatment approaches. This capability is particularly valuable in oncology, where tumor-derived organoids can be used to predict patient responses to chemotherapy or targeted therapies. As healthcare shifts towards personalized treatment strategies, the adoption of organoid-based models is expected to increase, further fueling market growth.

Moreover, the growing prevalence of chronic diseases, such as cancer, neurodegenerative disorders, and liver diseases, is another major factor driving market expansion. Organoids provide an advanced model to study these conditions, leading to a deeper understanding of disease mechanisms and the development of novel therapeutic interventions. For instance, brain organoids are being used to study neurological conditions like Alzheimer's and Parkinson's disease, while liver and kidney organoids are helping researchers develop treatments for organ failure.

Despite these positive trends, challenges such as ethical concerns, regulatory hurdles, and high costs associated with organoid development may pose limitations to some extent. However, ongoing research efforts and technological advancements are expected to address these challenges, paving the way for the broader adoption of organoids in biomedical and clinical applications.

Human Organoids Market Report Highlights:

• Based on product, the organoid models segment dominated the market in 2024. The large share is driven by increasing drug discovery, disease modeling, and regenerative medicine adoption.
• Based on organ type, the liver segment dominated the market in 2024. The large share is driven by its critical role in drug metabolism and toxicity testing.
• Based on source, the adult stem cells segment led the human organoids market in 2024, driven by their widespread use in disease modeling, drug discovery, and regenerative medicine.
• Based on application, developmental biology dominated the human organoids market in 2024. The large share is driven by its critical role in understanding cellular processes, tissue engineering, and organoid development.
• Based on end use, the pharmaceutical & biotechnology companies held the largest market share in 2024, driven by the increasing adoption of organoid technology in drug discovery, preclinical testing, and personalized medicine.
• In 2024, North America led the human organoids market, driven by strong investments in biotechnology, advanced healthcare infrastructure, and increasing adoption of organoid technology in drug discovery and personalized medicine.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Organ Type
  • 1.2.3. Source
  • 1.2.4. Application
  • 1.2.5. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Human Organoids Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising research on gut-related diseases
    • 3.2.1.2. Advancements in microbiome studies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High development costs
• 3.3. Human Organoids Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Organoids Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Human Organoids Market Product Movement Analysis
• 4.3. Global Human Organoids Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Media & Supplements
  • 4.4.1. Media & supplements market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Reagents
  • 4.5.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Organoid Models
  • 4.6.1. Organoid Models market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Human Organoids Market: Source Estimates & Trend Analysis

• 5.1. Source Segment Dashboard
• 5.2. Global Human Organoids Market Source Movement Analysis
• 5.3. Global Human Organoids Market Size & Trend Analysis, by Source, 2018 to 2030 (USD Million)
• 5.4. Adult Stem Cells
  • 5.4.1. Adult stem cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Induced Pluripotent Stem Cells
  • 5.5.1. Induced pluripotent stem cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Embryonic Stem Cells
  • 5.6.1. Embryonic stem cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Other Sources
  • 5.7.1. Other sources market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Human Organoids Market: Organ Type Estimates & Trend Analysis

• 6.1. Organ Type Segment Dashboard
• 6.2. Global Human Organoids Market Organ Type Movement Analysis
• 6.3. Global Human Organoids Market Size & Trend Analysis, by Organ Type, 2018 to 2030 (USD Million)
• 6.4. Stomach Models
  • 6.4.1. Stomach models market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Intestine Models
  • 6.5.1. Intestine models market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Liver Models
  • 6.6.1. Liver models market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Pancreatic Models
  • 6.7.1. Pancreatic models market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Lung Models
  • 6.8.1. Lung models market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Brain Models
  • 6.9.1. Brain models market estimates and forecasts 2018 to 2030 (USD Million)
• 6.10. Kidney Models
  • 6.10.1. Kidney models market estimates and forecasts 2018 to 2030 (USD Million)
• 6.11. Other Models
  • 6.11.1. Other models market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Human Organoids Market: Application Estimates & Trend Analysis

• 7.1. Application Segment Dashboard
• 7.2. Global Human Organoids Market Application Movement Analysis
• 7.3. Global Human Organoids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Developmental Biology
  • 7.4.1. Developmental biology market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Drug Toxicity & Efficacy Testing
  • 7.5.1. Drug toxicity & efficacy testing market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Disease Pathology
  • 7.6.1. Disease pathology market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Personalized Medicine
  • 7.7.1. Personalized medicine market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Regenerative Medicine
  • 7.8.1. Regenerative medicine market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Human Organoids Market: End Use Estimates & Trend Analysis

• 8.1. End Use Segment Dashboard
• 8.2. Global Human Organoids Market End Use Movement Analysis
• 8.3. Global Human Organoids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Pharmaceutical & Biotechnology Companies
  • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. CROs & CMOs
  • 8.5.1. CROs & CMOs market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Academic & Research Institutes
  • 8.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Other End Use
  • 8.7.1. Other end use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Human Organoids Market: Regional Estimates & Trend Analysis by Product, Organ Type, Source, Application, and End Use

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 9.4. North America
  • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Regulatory framework
    • 9.5.7.3. Competitive scenario
    • 9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key country dynamics
    • 9.5.8.2. Regulatory framework
    • 9.5.8.3. Competitive scenario
    • 9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.9. Denmark
    • 9.5.9.1. Key country dynamics
    • 9.5.9.2. Regulatory framework
    • 9.5.9.3. Competitive scenario
    • 9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. MEA
  • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Regulatory framework
    • 9.8.3.3. Competitive scenario
    • 9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key country dynamics
    • 9.8.4.2. Regulatory framework
    • 9.8.4.3. Competitive scenario
    • 9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key country dynamics
    • 9.8.5.2. Regulatory framework
    • 9.8.5.3. Competitive scenario
    • 9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. Company Profiles/Listing
  • 10.4.1. ATCC
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Thermo Fisher Scientific Inc.
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. STEMCELL Technologies
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Merck KGaA
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Corning Incorporated
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Bio-Techne.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. ACROBiosystems.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. .AMSBIO
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Qkine Ltd.
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. PRIMACYT Cell Culture Technology GmbH
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives